SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-003829
Filing Date
2011-01-25
Accepted
2011-01-25 07:00:45
Documents
4
Period of Report
2011-01-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v208856_8k.htm 8-K 34205
2 v208856_ex10-1.htm EX-10.1 23137
3 v208856_ex99-1.htm EX-99.1 11298
4 GRAPHIC pdl.jpg GRAPHIC 18753
  Complete submission text file 0001144204-11-003829.txt   96335
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 11545019
SIC: 2836 Biological Products, (No Diagnostic Substances)